The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.

Hunsaker finds an improvement in the “volume and variety” of funding from the UKIB and others since his original report into ...

My grandpa really loves golf,” Staunton senior Lilly Bandy said. “He’s always played, so I decided to try it out. I had never ...

Eli Lilly has thrown its weight behind a cause beyond the traditional remit of pharma companies. | Eli Lilly has thrown its ...

Artificial intelligence can revolutionize drug discovery by expediting development, reducing costs, and improving treatment ...

UNICEF is working to strengthen under-resourced health systems around the world to improve outcomes for children and family ...

As an investor in Eli Lilly stock, I'm encouraged by the company's forward thinking. Not only is management making moves to ...

This week’s news from the life sciences includes Eli Lilly's investment in a Cambridge-Singapore biotech, Stealth ...

Unfortunately, many of our elected leaders today undervalue the role of patents to progress the science of drug discovery and ...

The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...

Eli Lilly’s senior VP of information and R&D IT, Ramesh Durvasula, said Lilly will use AI and tech to transform the company.

There's no playbook for how to be competitive in artificial intelligence (AI) as a big pharma company, but Eli Lilly (NYSE: LLY) is taking a shot at developing one. With the appointment of a new chief ...